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ABSTRAK 
Tajuk: 
Perbandingan 'conjunctival impression cytology' diantara pesakit-pesakit glauk:oma yang 
dirawati dengan menggunakan ubat titis timolol maleate 0.5% dan pesakit-pesakit 
glaukoma yang dirawati dengan menggunakan ubat titis latanoprost 0.005%. 
Pengenalan: 
Ubat titis didapati boleh menyebabkan reaksi konjunktiva, tennasuk ubat titis anti-
glaukoma. Jangka masa rawatan yang panjang dipercayai telah menyebabkan kesan parut 
ke atas bleb filtrasi dan mempengaruhi kejayaan pembedahan filtrasi. Rawatan ubat titis 
timolol maleate 0.5% dan ubat titis latanoprost 0.005% yang berterusan menyebabkan 
perubahan morfologi pada permukaan mata. 
Objektif: 
Perbandingan antara kesan ubat titis timolol maleate 0.5% dengan kesan ubat titis 
latanoprost 0.005% pada morfologi pennukaan konjunktiva. 
Tatacara: 
Pesakit-pesakit glaukoma yang baru didiagnos dan layak dipilih sebagai subjek untuk 
kajian ini. Mereka telah dibahagikan kepada dua kumpulan. Kumpulan pertama dirawati 
dengan menggunakan ubat titis timolol maleate 0.5% manakala k:umpulan kedua dirawati 
dengan menggunakan ubat titis latanoprost 0. 005%. Sebelum rawatan ubat titis diberi 
XI 
kepada pesakit, 'conjunctival impression cytology' yang pertama diambil. Kemudian 
selepas tiga bulan rawatan, 'conjunctival impression cytology' yang kedua diperolehi. 
Perubahan morfologi pada permukaan konjunktiva sebelum dan selepas rawatan dikaji 
dalam setiap kumpulan. Perubahan morfologi permukaan konjunktiva diantara kedua-dua 
kumpulan pesakit juga dibandingkan. 
Keputusan: 
Seramai 39 pesakit glaukoma yang baru dikesan diambil untuk kajian ini. 20 pesakit 
dalam kumpulan Timolol manakala 19 pesakit dalam kumpulan Latanoprost. Selepas tiga 
bulan rawatan, didapati kedua-dua kumpulan pesakit tiada perubahan morfologi sel 
epithelia konjunktiva. Namum begitu, secara statistic didapati kekurangan bilangan set 
goblet dan mucos granule yang signifikan di kedua-dua kumpulan selepas rawatan tiga 
bulan diberi. Analisis dengan 'Independent T-test' menunjukkan tiada perbezaan 
bilangan set goblet dan mucos granule yang signifikan diantara dua kumpulan. 
Kesimpulan: 
Ini dapat disimpulkan bahawa selepas tiga bulan rawatan ubat titis timolol maleate 0. 5% 
dan ubat titis latanoprost 0.005% diber~ bilangan set goblet dan mucos granule didapati 
berkurangan. Namum begitu, tiada perubahan morfologi sel epithelia yang berlak:u dalam 
kedua-dua kumpulan. lni membuktikan bahawa ubat titis glaukoma, timolol maleate 
0.5% dan latanoprost 0. 005% boleh menyebabkan perubahan morfologi permukaan 
konjunktiva dalam masa tiga bulan. Namum begitu, tiada perbezaan perubahan morfologi 
pennukaan konjunktiva diantara kumpulan Timolol dan kumpulan Latanoprost. 
xu 
ABSTRACT 
Title: 
Comparison of conjunctival impression cytology between glaucoma patients treated with 
topical timolol maleate 0.5% and topicallatanoprost 0.005%. 
Introduction: 
All topical medications are known to cause conjunctival reactions, and topical anti-
glaucoma drugs are also no exception. Long term drug induced toxicity to the conjunctiva 
is postulated to cause filtering bleb scarring and filtration surgery failure. Chronic 
application of topical timolol maleate 0.5% and topical latanoprost 0.005% had been 
shown to alter the morphology of the conjunctival ocular surface. 
Objective: 
To compare conjunctival surface morphological changes with the use of the topical 
timolol maleate 0.5% and topicallatanoprost 0.005%. 
Methodology: 
Newly diagnosed glaucoma patients who met the selection criteria were randomly 
divided into two groups. One group treated with topical timolol maleate 0.5%, another 
group treated with topical latanoprost 0. 005%. Before the treatment was started, the first 
conjunctival impression cytology was taken. After three months of treatment, the second 
conjunctival impression cytology was obtained. The changes that occurred between the 
Xlll 
frrst and second conjunctival impression cytology in the individual group were analyzed. 
Conjunctival surface changes that occurred with the use of topical timolol maleate 0.5% 
were also compared with the conjunctiva surface changes that occurred with the use of 
topicallatanoprost 0. 005%. 
Results: 
There were thirty-nine newly diagnosed glaucoma patients included in this study. Twenty 
patients were in the Timolol group and nineteen patients in the Latanoprost group. In 
both groups of patients, there was no change of the conjunctival epithelial cell 
morphology after three months of anti-glaucoma therapy. However, there was statistically 
significant reduction of the goblet cell and mucous granule density in both groups of 
patients after three months of the topical anti-glaucoma therapy (P- value <0.001). By 
using the independent T -test, there was no significant difference of the goblet cell and 
mucous granule density between the Timolol group and the Latanoprost group after three 
months of treatment. 
Conclusion: 
This concludes that both timolol maeate 0.5% and topicallatanoprost 0.005% cause great 
reduction of conjunctival goblet cells and mucous granules within three months of 
treatment. However, the conjunctival epithelial cell morphology remained normal after 
three month of treatment in both groups of patients. This study gives evidence that topical 
timolol maleate 0.5% and topicallatanoprost 0.005% cause morphological changes ofthe 
conjunctival surface after short term (three months) therapy. However, there was no 
XIV 
difference in the conjunctival morphological changes between the Timolol group and 
Latanoprost group. 
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1. INTRODUCTION 
1.1 BACKGROUND 
The conjunctiva is a passive semi-permeable barrier that allows drugs to enter the eye. It 
is also a delicate tissue that can respond to stress with inflammation, scarring, 
keratinization and neovascularization (James D Brandt, 1991). These conjunctival 
changes will affect the tear film layer and it may affect the outcome of filtration surgery. 
Virtually all topically administered medications are known to cause conjunctival 
reactions, and the topical anti-glaucoma drugs are also no exception (James D Brandt, 
1991). Most patients undergo surgery only after months of topical drug treatment, and 
long term drug induced toxicity may predispose patients to poor outcome after filtration 
surgery. 
Lavin MJ and associates found that long term use (more than one year duration) of 
topical anti-glaucoma medications can adversely affect the result of filtration surgery 
(Lavin MJ et al, 1990). The results of the study done by Sherwood :MB and associates 
suggest that exhaustive medical therapy, before filtration surgery is offered, increases the 
number of tissue inflammatory cells and decreases the number of epithelial goblet cells 
(Sherwood MB, 1989). 
The expression of:E~A-DR on conjunctival epithelial cells in patients taking topical anti-
glaucoma eye drops also indicates the increased ability of epithelial cells to induce 
immune inflammation with subsequent fibrosis (Ihan A et al, 2000). There was also an 
I 
increase in myofibroblastic cell proliferation in fistulized rabbit conjunctiva treated with 
glaucoma medication compared with fistulized conjunctiva that was not treated with 
topical eye drops (Terri L Young et al, 1990). These tissue cellular changes may enhance 
the external bleb scarring and filtration surgery failure (Sherwood :MB, 1989). Patients on 
long term multiple topical anti-glaucoma drugs was postulated to have lower 
trabeculectomy success rate in comparison with patients undergoing primary 
trabeculectomy (Broadway David, 1993). The number of the conjunctival goblet cells 
may also relate to intraocular pressure control after trabeculectomy (Gwynn DR, 1993). 
There are few classes of anti-glaucoma drugs. Beta-adrenergic receptor blocker- topical 
timolol maleate 0.5% is usually used as the first line medication in most of the glaucoma 
cases in the absence of systemic contraindication. However, it has been shown that 
chronic application of a commercial preparation of topical timolol maleate 0.5% altered 
the morphology of conjunctiva ocular surface and impairing the quantity and quality of 
the mucous layer of the tear film (Herreras JM et al, 1992). Recently, there is increasing 
usage oftopicallatanoprost 0.005%- a prostaglandin F2a. analogue. It has been used as a 
first line treatment in some medical centers. Chronic application of topical latanoprost 
0.005% also has adverse effect on the ocular surface (Fraunfelder et al, 2002). 
Slit-lamp examination of the ocular surface with or without flourescein or Rose Bengal 
staining gives only a rough idea about the changes occurring in the epithelium. However, 
the histological section, which gives better histological information, can cause scarring to 
2 
the conjunctiva. The use of impression cytology had been proven to be a good method for 
conjunctival surface assessment. 
The conjunctival impression cytology can be obtained by the apposition of cellulose 
acetate filters onto the conjunctiva. This method is less invasive, easy and cheap to be 
performed. It has been used in identifying conjunctival changes related to long term 
topical anti-glaucoma drug use (James D Brandt et al, 1991). 
In this study, the conjunctival impression cytology done for the patients using topical 
timolol maleate 0.5% and patients using topicallatanoprost 0.005% might reveal valuable 
information regarding the conjunctival surface morphological changes that developed 
with the use of the respective topical anti-glaucoma drug. 
1.2 CONJUNCTIVA 
The conjunctiva is a thin mucous membrane that lines the eyelids. It is reflected at the 
superior and inferior fornices onto the anterior surface of the eyeball. Histologically, the 
conjunctiva has an epithelial covering of stratified columnar cells consisting of two to 
five layers resting on a substantia propria of loose connective tissue. Goblet cells are 
found scattered along the surface of the conjunctiva and it is most numerous over the 
infero-nasal part of the bulbar conjunctiva (Kirk RW et al, 1999). Their mucous secretion 
is important contributing stability to the tear film. The conjunctiva also acts as a semi-
3 
permeable membrane, allowing the entry of topical medications. The side effects of the 
medications might cause morphological changes of the conjunctiva. 
In glaucoma-filtering surgery, a fistula is created between the anterior chamber and the 
subtenon space. The conjunctival bleb is formed between the bulbar conjunctiva and the 
subtenon space. Thus the success rate of the glaucoma-filtration surgery depends on 
many factors, not the least of which is the existence of a healthy conjunctiva. Therefore it 
is important to identify the conjunctival morphological changes that developed with the 
use of the topical anti-glaucoma drugs. 
1.3 CONJUNCTIVAL IMPRESSION CYTOLOGY 
Conjunctival impression cytology is a method of obtaining cytological specimen from the 
conjunctival surface. It refers to the application of cellulose acetate paper to the ocular 
surface to remove the superficial layer of conjunctival epithelium. It has high cell pick up 
rate and detailed cell resolution is achieved after fixation and staining procedure (Divani 
SN et al, 1997). With this method, the morphology of the conjunctival surface can be 
studied. This technique is non invasive, easy to perform and causes minimal discomfort 
to patients (Divani SN et al, 1997). 
4 
1.3.1 THE USE OF CONJUNCTIVAL IMPRESSION CYTOLOGY IN OCULAR 
SURFACE ASSESSMENT 
Egbert et al first introduced ocular impression cytology into ophthalmology field in 1977. 
These authors used cellulose acetate filter paper for the collection of the superficial layer 
of cells from conjunctiva. This method has subsequently been modified by several 
authors for investigation of a variety of ocular surface disorders. It has provided insights 
into a number of ocular surface disorders, including dry eyes (Nelson JD et al, 1983), 
vernal keratoconjunctivitis, hypovitaminosis A (Polizzi A et al, 1998)(Keenum DG et al, 
1990), squamous metaplasia (Tole DM et al, 2001)(Scheffer CG Tseng, 1985), ocular 
pemphigoid, Stevens Johnson syndrome and also in detecting superficial viral infection 
of the eye (Thiel MA et al, 1997). 
An immunocytological study was done by using conjunctival impression cytology to 
investigate the expression of two inflammatory markers, class IT :MHC antigens Ill.. A DR 
and the receptor to IgE (CD23) in normal and diseased conjunctiva (Christophe 
Baudouin, 1992). Thiel et al have described the use of a new Biopore membrane device 
for obtaining conjunctival cells for the diagnosis of superficial viral infection. 
Immunocytological staining of these samples can provide virological results within one 
to four hours (Thiel MA et al, 1997). Tole et al also having success with impression 
cytology in the diagnosis of ocular surface squamous neoplasia using Biopore membrane 
(Tole DM et al, 2001). However, the cellulose acetate papers offer greater sampling 
flexibility. Scheffer CG Tseng (1985) had differentiated the process of squamous 
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metaplasia of conjunctival epithelium into six stages by impression cytology using 
cellulose acetate paper. Electron microscopy of impression-acquired conjunctival 
epithelial cells also has potential for the study of sub-cellular, cellular and intercellular 
morphology in diseases of the ocular surface (Steven L Maskin et al, 1986). 
1.3.2 METHODS OF FIXATION AND STAINING OF IMPRESSION 
CYTOLOGYSPECDWENS 
The conjunctival impression cytology samples were fixed with a mixture of 70% alcohol, 
37% folmaldehyde and glacial acetic acid (Figure 6). There are a few staining methods of 
the conjunctival impression cytology specimens, like haematoxylin and periodic acid 
Schiff stain (PAS), Toluidine blue staining, Papanicolaou staining, peroxidase staining 
and immunoflourescence staining. The commonest stain used was haematoxylin and 
periodic acid Schiff stain. It provides good staining and visualization of conjunctival 
epithelium and goblet cells. 
Periodic acid Schiff stain is a special stain for demonstration of mucin, reticulum and 
glycogen. The reaction is based on the fact that certain tissue elements are oxidized by 
the periodic acid, one of the reaction products being aldehyde. The Periodic acid cleaves 
the carbon-carbon bonds where those carbon atoms have adjacent hydroxyl group ( -OH), 
or adjacent hydroxyl and amino groups ( -NH2). The Schiff reagent (Figure 9) is used to 
demonstrate the aldehyde produced after hydrolysis with hydrochloric acid (Culling 
CFA, 1983). 
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Sodium metabilsulfite is used as a buffer for the removal of excessive Schiff reagent. 
Counterstaining of the nucleus is by the haematoxylin stain (Figure 1 0) whereas 
dehydration is done with the alcohol (Figure II). Xylene solution acts as a clearing agent. 
The tissue become clearer as the alcohol is replaced owing to the difference in the 
refractive index. 
The haematoxylin and periodic acid Schiff's staining procedure was as follows: (I) rinse 
with distilled water for 2 minutes; (2) immerse in 0.05% periodic acid for 2 minutes 
(Figure 7); (3) rinse with distilled water; ( 4) immerse in Schiff reagent diluted I: I with 
water for 8 minutes (Figure 9); ( 5) rinse with tap water for 2 minutes; ( 6) immerse in 
0.05% sodium metabilsulfite for 2 minutes; (7) rinse with tap water for 2 minutes; (8) 
stain with haematoxylin for 30 seconds (Figure IO); (9) rinse with tap water for 2 
minutes; (IO) decolorized for 2 minutes using 95% alcohol (Figure II); (II) decolorized 
with absolute alcohol for another 2 minutes (Figure II); (12) transfer to xylene solution 
for IO minutes; (I3) allow the slide to dry; (I4) the specimen is ready for mounting 
(Figure I2). 
1.3.3 STANDARDIZATION OF CONJUNCTIVAL IMPRESSION CYTOLOGY 
Martinz et al ( I995) found that the conjunctival cell pick up rate was dependant on the 
pore size of the filter paper and the pressure applied during the apposition of the filter 
paper to the conjunctival surface. The maximum cell acquisition was achieved by filter 
paper with medium pore size (0.22J.Lm) and a pressure of 60g during the sampling 
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procedure. In this study, Millipore GSWP01300 filter papers with the pore size of 
0 .22J.1m were used for the conjunctival impression cytology. 
1.4 TOPICAL ANTI-GLAUCOMA DRUGS 
There are a few classes of topical anti-glaucoma drugs: 
I. Beta adrenergic receptor blockers: Timolol, Levobunolol, Betaxolol, Carteolol, 
Metipranolol. They lower the intraocular pressure by decreasing the aqueous 
production. 
2. Prostaglandin agonist: latanoprost. It lowers the intraocular pressure by increasing the 
uveoscleral outflow. 
3. Cholinergics (Direct acting): pilocarpine, carbachol, aceclidine. They increase the 
aqueous drainage through the trabecular meshwork by opening up the anterior 
chamber angle. 
4. Cholinergics: Cholinesterase inhibitors (Indirect acting): physostigmine, demecarium, 
edrophonium, ecothiophate, isoflorophate. Their mechanism of action is same as the 
cholinergic eye drops. 
5. Adrenergic agonists: epinephrine, dipivefrin, apraclonidine, brimonidine. They 
reduce aqueous production by alpha 2 effect and increase aqueous drainage by beta 2 
effect. 
6. Carbonic anhydrase inhibitors: dorzolamide hydrochloride. They decrease aqueous 
production by inhibiting the carbonic anhydrase. 
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1.4.1 TOPICAL TIMOLOL MALEATE 0.5% 
Topical timolol maleate 0.5% is commonly used in our clinical practice. It is a 
nonselective betal and beta 2 adrenergic antagonist. The composition of the drug is 
timolol maleate (O.Sg/IOOml), monosodium crystalline phosphate I H20 (0.37g/IOOml), 
benzalkonium chloride (O.Oig/IOOml), crystalline sodium chloride (0.22g/IOOml), 
disodium crystalline phosphate I H20 (2.60g/100ml), and purified water (lOOml). It is 
useful in treatment of all types of glaucoma, irrespective of the state of the angle. In the 
absence of systemic contraindications, it is frequently the frrst choice medication. It 
antagonizes the effects of beta agonists at beta-receptors by competing with 
catecholamines and it reduces the intraocular pressure by decreasing aqueous secretion. 
The side effect of topical timolol maleate can be divided into systemic side effects and 
ocular side effects. The main systemic side effects are bronchial constriction and 
cardiovascular side effects such as bradycardia, decreased cardiac contractility and 
prolongation of atrio-ventricular conduction. Ocular allergic and toxic reactions with 
timolol therapy have been reported. Burning and conjunctival hyperaemia may 
occasionally occur and are frequently associated with superficial punctate keratopathy 
and corneal anaesthesia. Chronic therapy with timolol has been shown to damage the 
ocular surface and impair the quantity and quality of the mucus layer of the tear film 
(Herreras et al, 1992) (James D Brant et al, I991) (Christophe Baudouin et at, 1999). 
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1.4.2 TOPICAL LATANOPROST 0.005% 
Latanoprost 0.005% is a new prostaglandin F2-alpha analogue with intraocular pressure 
lowering effect at least equal to timolol 0. 5% (Peter Watson et al, 1996) or better than 
timolol 0.5% (Carl B Camras et al, 1996). Each ml of latanoprost 0.005% contains 50 
meg latanoprost and benzalkonium chloride 0. 02g/1 OOml. Other ingredients include 
sodium chloride, sodium dihydrogen phosphate monohydrate and disodium phosphate 
anhydrous water. It enhances uveoscleral outflow and its pressure lowering effect is 
therefore additive to most other medications. 
It has little systemic side effect. Local side effects consisting mainly of ocular irritation 
and mild conjunctival hyperaemia occur in about 10% of patients. It is contraindicated in 
uveitis as it exacerbates the inflammation. It may also cause increased pigmentation of 
the iris and hypertricosis. Cystoid macular edema had been reported with the use of 
latanaprost in the aphakic and pseudophakic eyes. Treatment with latanoprost also 
produced conjunctival morphological changes (Robert J Noecker, 2003). 
1.4.3 COMPARISON BETWEEN TOPICAL TIMOLOL MALEATE 0.5°/o AND 
TOPICAL LATANOPROST 0.005% 
Topical timolol maleate 0.5% is the frrst line topical anti-glaucoma drug that we 
commonly use. Topical latanoprost 0.005% is a newer topical anti-glaucoma drug. 
Latanoprost 0. 005% admininistered once daily reduced intraocular pressure as well as 
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timolol 0.5% administered twice daily (Peter Watson et al, 1996). The study done by Carl 
B Camras et al revealed that the intraocular pressure reduction achieved with latanoprost 
0.005% is greater than that produced with timolol 0.5% (Carl B Camras et al, 1996). The 
aim of this study is to compare the ocular surface changes caused by the topical 
latanoprost 0.005% and the topical timolol maleate 0.5%. 
Christophe Baudouin and associates ( 1999) found that Benzalkonium Chloride induces 
histopathological and inflammatory changes in the ocular surface and in deeper ocular 
structures treated by anti-glaucoma drugs. Pisella PJ et al (2002) also found that the 
ocular symptoms and signs of irritation are less prevalent when preservative~ free drops 
are used. The topical timolol maleate 0.5% contains 0.01g/100ml benzalkonium chloride 
whereas topical latanoprost 0.005% contains 0.02g/100ml benzalkonium chloride. 
However, the topical timolol maleate 0.5% is used twice daily whereas topical 
latanoprost 0.005% is used once daily. Therefore the patients treated with topical timolol 
maleate 0.5% and the patients treated with topicallatanoprost 0.005% will receive equal 
amount of benzalkonium chloride daily. 
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2. OBJECTIVES 
2.1. GENERAL OBJECTIVE 
To compare conjunctival surface morphological changes with the use of topical timolol 
maleate 0.5% and topicallatanoprost 0.005%. 
2.2. SPECIFIC OBJECTIVE 
1. To evaluate and compare the conjunctival epithelial cell morphology between 
the Timolol group and Latanoprost group. 
2. To evaluate and compare the conjunctival goblet cell density between the 
Timolol group and Latanoprost group. 
3. To evaluate and compare the conjunctival mucous granule density between the 
Timolol group and Latanoprost group. 
12 
3. MATERIALS AND METHODS 
3.1 RESEARCH STRATEGY 
Randomized clinical trial. 
3.2 POPULATION, SETTING AND TIME 
Study populations: Group 1: Newly diagnosed glaucoma patients treated with topical 
timolol maleate 0.5% twice daily. 
Period of study: 
Group 2: Newly diagnosed glaucoma patients treated with topical 
latanoprost 0. 005% once at night. 
August 2002 till November 2003. 
Places of sampling: I. Ophthalmology Clinic, Department of Ophthalmology, School of 
Medical Science, Universiti Sains Malaysia. 
2. Ophthalmology Clinic, Hospital Kota Bahru. 
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3.3 SAMPLING, CASE ALLOCATION AND SAMPLE SIZE 
3.3.1 SAMPLING METHOD 
Randomized sampling was done. Newly diagnosed glaucoma patients were randomly 
divided into two groups, by closed envelope method. One group was put on topical 
timolol maleate 0.5% twice daily, and another group on topicallatanaprost 0.005% once 
at night. If both eyes of a single patient were glaucomatous and met the inclusion criteria, 
one of the eyes would be chosen randomly for the study by closed envelope method. The 
investigator was blinded from the grouping of the patients. The first conjunctival 
impression cytology was taken before the treatment was started. The second conjunctival 
impression cytololgy was obtained after three months of treatment. The conjunctival 
surface changes were evaluated in each group of patients. The effects of the topical 
timolol maleate 0.5% and topical latanoprost 0.005% to the morphology of the 
conjunctival surface were also compared. 
3.3.2 SAMPLE SIZE CALCULATION 
The calculation of the sample size was based on the previous studies and was calculated 
using two means formula programmed in the computer. The calculation was made based 
on these assumptions: confidence interval of 95%, power of study 80%, the different 
mean of goblet cell density (L\) between the patients using topical timolol maleate 0.5% 
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and patients using topical latanaprost 0. 005% was 25±27 cells/mm2, the constant value 
was za.:l.96 and zf3:o.84 (study power). 
Two mean formula: 
11= 2ci' (Za. + Zf3)2 
A? 
= 2x27x27 (1.96+0.84)2 
25x2 
= 1458 (2.8i 
625 
= 2.3328 X 7.84 
= 18.289 
There were 2 groups of eyes: 
Group I : included at least 19 newly diagnosed glaucomatous eyes, treated with topical 
timolol maleate 0.5% twice daily. 
Group 2: included at least I 9 newly diagnosed glaucomatous eyes, treated with topical 
latanoprost 0.005% once daily. 
3.4 SELECTION CRITERIA 
3.4.1 INCLUSION CRITERIA 
Newly diagnosed primary open angle glaucoma patients and primary chronic angle 
closure glaucoma patients without acute and sub-acute attack, age ranged from 40 to 80 
years. 
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3.4.2 EXCLUSION CRITERIA 
1. Previous history of ocular surgery and ocular trauma. 
2. Chronic use of any topical eye drops for more than 1 month. 
3. Patient with history and/ or clinical findings of acute and sub-acute attack of angle 
closure glaucoma. 
4. Secondary glaucoma. 
5. Inflammatory eye diseases. 
6. Contact lens wear. 
7. Evidence of severe ocular surface disorder on slit-lamp examination ( eg. severe dry 
eye). 
8. Patients who need more than one type of anti-glaucoma eye drops during the study 
period (First 3 months of treatment). 
9. Patients who did not compliance to the treatment of topical anti-glaucoma drugs. 
10. Diabetes mellitus patients with diabetic retinopathy or poor diabetic control. 
3.5 ETHICAL APPROVAL 
This study was approved by the Research and Ethics Committee, School of Medical 
Sciences, Universiti Sains Malaysia on 21 August 2002. This was supported by the USM 
short term grant (Reference number: 304/PPSP/6131263). 
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3.6 DEFINITION OF TERMS 
I. Primary open angle glaucoma (POAG) 
It is a multi-factorial syndrome in which acquired progressive optic nerve damage is 
related, at least in part, to intraocular pressure higher than the nerve fibers can tolerate. 
POAG consists of a variety of variably overlapping entities. Although the etiological 
factors of the individual entities, or the broader group of conditions called POAG, are 
unknown, POAG is secondary to as-yet-unrecognized forces. The term primary itself 
suggests an unknown cause. 
POAG is a group of chronic, bilateral conditions that are almost always symmetrical. It is 
characterized by the following features: evidence of glaucomatous optic nerve damage; 
adult onset; normal-appearing, open anterior chamber angles; and absence of other 
known causes of open-angle glaucoma. In the case of glaucomatous optic nerve damage, 
the characteristic appearance of the optic disc and retinal nerve fiber layer includes 
thinning or notching of the tissue of the neuroretinal rim of the disc, a progressive 
increase in cupping of the optic nerve, retinal nerve fiber layer defects, and flame-shaped 
haemorrhage crossing the outer edge of the disc. The presence of damage to the visual 
field is evidenced by arcuate defect, nasal step, para-central scotoma and generalized 
depression in the absence of other causes or explanations for the field defect. 
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POAG can be classified solely based on the intraocular pressure level, into two 
categories: the high-tension type, in which intraocular pressure elevates above the 
statistically normal range, which is above 21mmHg, and the low -tension type (low-
tension glaucoma or normal-tension glaucoma, in which the intraocular pressure is 
consistently in the statistically normal range. The two subgroups of POAG overlap and 
the clinical difference between the two subgroups are not always clear cut (Tarek M Eid 
and George L Spaeth, 2000). 
2. Pseudoexfoliation glaucoma: It is a form of primary open angle glaucoma. In 
pseudoexfoliation glaucoma, a grey-white, fibrillogranular material is deposited in and 
around the anterior segment of the eye. The origin of the fibrillogranular material is 
multifocal. It is from the abnormal basement membrane produced by aging epithelial 
cells. Exfoliation materials were demonstrated in the conjunctival stroma of 
pseudoexfoliation glaucoma patients. However, there was no evidence of exfoliation 
materials near basement membrane of conjunctival epithelium and blood vessels. The 
basement membrane of conjunctival epithelium showed no remarkable abnormalities 
(Young Bae Rob et al, 1987). 
3. Primary chronic angle closure glaucoma (Chronic PACG) 
It is appositional or synechial closure of the anterior chamber angle caused by the 
pupillary block in the absence of other causes of angle closure. Slowly progressive 
closure of the angle may lead to sustained elevation of intraocular pressure. Symptoms 
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usually are absent until visual field loss becomes advanced. Patients with chronic P ACG 
have no evidence of a previous acute attack of pupillary block by history or physical 
examination. In early cases, the glaucoma is due to appositional angle closure without 
peripheral anterior synechiae formation. Later on, progressive peripheral anterior 
synechiae formation develops (synechia! angle closure). This chronic form of angle 
closure may be complicated by a superimposed acute episode, presumably triggered by 
other mechanisms of action ( eg. cataract). A rare variant of angle closure, creeping angle 
closure, may occur, especially in patient with dark brown irises. In this form, the closure 
begins anterior to the ciliary body, near the Schwalbe's line, such that the posterior 
trabecular meshwork may remain open, bridged by the synechiae. Eventually, there may 
be an acute attack, or the peripheral anterior synechiae may permanently occlude the 
angle, leading to elevated intraocular pressure and glaucomatous damage. 
On examination of the chronic P ACG, the intraocular pressure is elevated, anterior 
chamber is quiet and usually deeper than in patients who have acute attacks, there is no 
corneal oedema, and the angle is operatively closed, with or without peripheral anterior 
synechiae. Presence of Glaucomflecken and/or sector atrophy of the iris indicates a 
previous acute attack. The optic disc and visual field show glaucomatous damage similar 
to that seen with POAG ((Tarek M Eid and George L Spaeth, 2000). 
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4.1mpression cytology 
It refers to the technique by which the superficial layers of the ocular surface are removed 
with the application of cellulose acetate filter materials. 
5. Conjunctiva 
It is a thin mucous membrane that lines the eyelids and is reflected at the superior and 
inferior fornices onto the anterior surface of the eyeball. It is divided into bulbar 
conjunctiva and palpebral conjunctiva. In this study, the impression cytology was taken 
from the superior bulbar conjunctiva. 
6. Topical timolol maleate 0.5% 
It is a type of topical anti-glaucoma drug. It is a non-selective beta 1 and beta 2 
adrenergic antagonist. It reduces the intraocular pressure by decreasing aqueous 
secretion. 
7. Topicallatanoprost 0.005% 
It is a prostaglandin F2a. analogue. It enhances uveo-scleral outflow thereby lowering the 
intraocular pressure. 
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3. 7 EQUIPMENT 
1. Topical anesthesia (4% novesin) (Figure 2) 
2. Millipore filter paper (GSWP01300) (Figure 5) 
3. Glass slide (Figure 1) 
4. Adhesive tape 
5. 70% alcohol (Figure 11) 
6. 30% formaldehyde 
7. Glacial acetic acid 
8. Periodic acid Schiff stain and Haematoxylin stain (Figure 9) (Figure 1 0) 
9. Sodium metabilsulfite 
10. 95% acid alcohol (Figure 11) 
11. Absolute alcohol (Figure 11) 
12. Xylene solution 
13. Light microscope (Leica DlMR) (Figure 14) 
14. Leica Qwin Software 
15. Leica Q 5001w (CPU) computer (Figure 14) 
3.8 COLLECTION OF DATA 
3.8.1 CONSENT 
Informed written consent was taken from all the patients. 
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3.8.2 mSTORY AND CLINICAL EXAMINATION 
Patients were randomly divided into 2 groups as mentioned earlier. The person who was 
going to do the conjunctival impression cytology and examination of the specimen was 
masked from the grouping of the patients. Patient's demographic data were recorded in 
the data collection form. Detailed history was asked from every patient: any history of 
allergic conjunctivitis, usage of any topical medications, contact lens wearing, history of 
ocular and conjunctival surgery, ocular trauma, any symptoms of ocular surface 
disorders, past medical history etc. Only those patients who fulfilled the selection criteria 
would be included in the study. Patients with history of acute and sub-acute attack of 
angle closure glaucoma were excluded from the study. 
All the eyes were examined under slit-lamp to identify any ocular surface abnormalities. 
Patients with any evidence of external eye disease or inflammatory eye diseases were 
excluded. For both groups of newly diagnosed glaucoma patients, the first conjunctival 
impression cytology was taken just before commencing the topical anti-glaucoma 
treatment. The second conjunctiva impression cytology was taken after 3 months of the 
treatment. 
3.8.3 METHOD OF SPECIMEN COLLECTION 
Patients were explained about the detail of the procedure and the written consent was 
taken. He/she was then asked to lie supine on an examination couch. Topical anaesthesia 
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Novesin 0.4% (Figure 2) was instilled into the eye before the procedure. One piece of 
round filter paper (Millipore GSWP01300) was cut equally into two pieces. The patient 
was instructed to look down towards the chest. One piece of the filter paper was held 
using a forceps and placed against the superior bulbar conjunctiva 2 mm away from the 
superior limbus (Figure 3). The straight cutting edge of the filter paper was directed 
towards the limbus. The filter paper was pressed gently for 3 seconds with the blunt end 
of the forceps, to ensure close contact of the filter paper with the ocular surface. After 
gentle pressure for 3 seconds, the filter paper was removed with a peeling movement 
(Figure 4). The reflection of the filter paper would become faded if the specimen had 
adhered to it. The filter paper was then adhered to the glass slide by adhesive tape with 
the specimen facing up (Figure 5). 
Figure 1: Fixation solution, slides and forceps used m specimen collection during 
conjunctival impression cytology. 
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Figure 2: Novesin 0.4%, the local anaesthetic solution used during conjunctival 
impression cytology. 
Figure 3: Filter paper placed on the superior bulbar conjunctiva. 
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